ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2025; 86(0): 102-110


Influence of Systemic Ampicillin or Pen-Strep and Intrauterine Oxytetracycline Combined with Systemic PGF2α or Estradiol on the Clinical Recovery and Fertility of Crossbred Kenana Affected by Clinical Metritis

Ibrahim M.I. Mohammedain, Reham Waheeb, Wael M. Noseir, Sayed A. Hattab.



Abstract
Download PDF Post

The study aimed to evaluate the effects of four therapies for clinical metritis (CM) treatment on recovery and reproductive performance in crossbred Kenana × Holstein dairy cows in Khartoum, Sudan. A total of 87 cows with CM were divided into six groups: G1 (control negative - CN) (n = 10) with healthy cows; G2 (control positive - CP) (n = 10) with untreated CM cows; G3 (Ampicillin treated) (n = 14); G4 (Penicillin and streptomycin treated) (n=17); G5 (Oxytetracycline and PGF2α treated (OTC+ PGF2α)) (n=18); and G6 (Oxytetracycline and estradiol benzoate treated OTC+EB) (n=18). The results indicated that the OTC + EB and Penicillin + streptomycin groups had significantly shorter intervals from treatment to service (P

Key words: Antibiotics, hormones, clinical metritis, reproductive performance, cross, kenana







Bibliomed Article Statistics

32
28
25
28
14
26
17
26
16
24
22
2
R
E
A
D
S

30

33

26

18

17

13

12

31

60

72

22


D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.